Carl Zeiss Meditec/€AFX
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Carl Zeiss Meditec
Carl Zeiss Meditec AG, publicly traded under the ticker symbol AFX, specializes in the healthcare technology sector. Founded in 2002 as a spin-off from Carl Zeiss AG, it provides comprehensive medical solutions for ophthalmology and microsurgery. Operating globally, the company combines its expertise in optics, electronics, and precision engineering to offer innovative products that enhance patient care and clinical outcomes.
Ticker
€AFX
Sector
Primary listing
XETRA
Industry
Health Care Equipment and Supplies
Headquarters
Employees
5,713
ISIN
DE0005313704
AFX Metrics
BasicAdvanced
€4.5B
28.71
€1.77
1.23
€0.60
1.18%
Price and volume
Market cap
€4.5B
Beta
1.23
52-week high
€71.65
52-week low
€44.28
Average daily volume
117K
Dividend rate
€0.60
Financial strength
Current ratio
2.044
Quick ratio
1.056
Long term debt to equity
27.279
Total debt to equity
28.461
Dividend payout ratio (TTM)
33.69%
Interest coverage (TTM)
5.67%
Profitability
EBITDA (TTM)
236.372
Gross margin (TTM)
52.43%
Net profit margin (TTM)
7.19%
Operating margin (TTM)
8.20%
Effective tax rate (TTM)
23.26%
Revenue per employee (TTM)
€380,000
Management effectiveness
Return on assets (TTM)
3.48%
Return on equity (TTM)
7.47%
Valuation
Price to earnings (TTM)
28.707
Price to revenue (TTM)
2.063
Price to book
2.14
Price to tangible book (TTM)
11.45
Price to free cash flow (TTM)
53.891
Free cash flow yield (TTM)
1.86%
Free cash flow per share (TTM)
94.45%
Dividend yield (TTM)
1.18%
Forward dividend yield
1.18%
Growth
Revenue change (TTM)
5.21%
Earnings per share change (TTM)
-39.40%
3-year revenue growth (CAGR)
7.74%
10-year revenue growth (CAGR)
8.65%
3-year earnings per share growth (CAGR)
-15.73%
10-year earnings per share growth (CAGR)
8.26%
3-year dividend per share growth (CAGR)
-12.64%
10-year dividend per share growth (CAGR)
4.14%
What the Analysts think about AFX
Analyst ratings (Buy, Hold, Sell) for Carl Zeiss Meditec stock.
Bulls say / Bears say
Bernstein reinstated coverage on Carl Zeiss Meditec with an 'Outperform' rating and a price target of €71, citing the company's strong market position and anticipated recovery starting in fiscal years 2024/25. (Investing.com)
The upcoming product launches, such as Kinevo 900 S and Visumax 800 in China, are expected to contribute significantly to the company's recovery and growth. (Investing.com)
Bernstein forecasts a Compound Annual Growth Rate (CAGR) of +9% from 2024/25 to 2028/29 for Carl Zeiss Meditec's top-line, and an even more robust +18% growth in Earnings Per Share (EPS). (Investing.com)
In June 2024, Carl Zeiss Meditec lowered its revenue forecast due to sluggish demand, now anticipating around €2 billion for the fiscal year, down from the previous target of €2.1 to €2.15 billion. (MarketScreener)
The company also revised its operating profit (EBIT) expectations to between €215 and €265 million, significantly below the previous year's target of over €348 million. (MarketScreener)
Following the announcement of the lowered revenue forecast, Carl Zeiss Meditec's shares fell by more than 16%, reaching their lowest level since March 2020. (Eulerpool)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.
AFX Financial Performance
Revenues and expenses
AFX Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Carl Zeiss Meditec stock?
Carl Zeiss Meditec (AFX) has a market cap of €4.5B as of July 18, 2025.
What is the P/E ratio for Carl Zeiss Meditec stock?
The price to earnings (P/E) ratio for Carl Zeiss Meditec (AFX) stock is 28.71 as of July 18, 2025.
Does Carl Zeiss Meditec stock pay dividends?
Yes, the Carl Zeiss Meditec (AFX) stock pays dividends to shareholders. As of July 18, 2025, the dividend rate is €0.6 and the yield is 1.18%. Carl Zeiss Meditec has a payout ratio of 33.69% on a trailing twelve-month basis.
When is the next Carl Zeiss Meditec dividend payment date?
The next Carl Zeiss Meditec (AFX) dividend payment date is unconfirmed.
What is the beta indicator for Carl Zeiss Meditec?
Carl Zeiss Meditec (AFX) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.